Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Significance of glutathione peroxidase 4 and intracellular iron level in ovarian cancer cells—“utilization” of ferroptosis mechanism
Dingxi Li, Mengli Zhang, Hongtu Chao
Inflammation Research (2021) Vol. 70, Iss. 10-12, pp. 1177-1189
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

GPX4: The hub of lipid oxidation, ferroptosis, disease and treatment
Yi Liu, Yicong Wan, Yi Jiang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188890-188890
Closed Access | Times Cited: 208
Ferroptosis, necroptosis, and pyroptosis in the occurrence and development of ovarian cancer
Chunmei Zhang, Ning Liu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 56
FANCD2 inhibits ferroptosis by regulating the JAK2/STAT3 pathway in osteosarcoma
Xujun Li, Jiangyi Liu
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 29
Mitochondrial chaperonin DNAJC15 promotes vulnerability to ferroptosis of chemoresistant ovarian cancer cells
Stefano Miglietta, Manuela Sollazzo, Iacopo Gherardi, et al.
Open Biology (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
RBM15 silencing promotes ferroptosis by regulating the TGF‐β/Smad2 pathway in lung cancer
Jing Feng, Yaling Li, Fen He, et al.
Environmental Toxicology (2023) Vol. 38, Iss. 4, pp. 950-961
Closed Access | Times Cited: 15
Inhibition of FSP1: A new strategy for the treatment of tumors (Review)
Qiangfang Dai, Xiaoli Wei, Jumei Zhao, et al.
Oncology Reports (2024) Vol. 52, Iss. 2
Open Access | Times Cited: 5
Nature-Inspired Bioactive Compounds: A Promising Approach for Ferroptosis-Linked Human Diseases?
Sarah El Hajj, Laetitia Canabady‐Rochelle, Caroline Gaucher
Molecules (2023) Vol. 28, Iss. 6, pp. 2636-2636
Open Access | Times Cited: 12
Daphnetin induces ferroptosis in ovarian cancer by inhibiting NAD(P)H:Quinone oxidoreductase 1 (NQO1)
Ning Ma, Mengwen Zhang, Jianqiang Hu, et al.
Phytomedicine (2024) Vol. 132, pp. 155876-155876
Open Access | Times Cited: 4
Research Advances in Ferroptosis in Ovarian Cancer: From Mechanism to Therapy
柳青 张
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 2394-2404
Closed Access
The intersection of ferroptosis and non-coding RNAs: a novel approach to ovarian cancer
Yi Jiang, Tamara Nazar Saeed, Karar H. Alfarttoosi, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Exploring the Association Between Aging, Ferroptosis, and Common Age-Related Diseases
Laleh Mavaddatiyan, Saghi Hakimi Naeini, Sara Khodabandeh, et al.
Archives of Gerontology and Geriatrics (2025), pp. 105877-105877
Closed Access
Ferroptosis: An emerging strategy for managing epithelial ovarian cancer
Carmen Alarcón-Veleiro, I López-Calvo, L Berjawi, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 187, pp. 118065-118065
Closed Access
Current progress of ferroptosis study in ovarian cancer
Zhuomin Tan, Hui Huang, Wenyan Sun, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 18
Study of Ferroptosis Transmission by Small Extracellular Vesicles in Epithelial Ovarian Cancer Cells
Carmen Alarcón-Veleiro, Rocío Mato-Basalo, Sergio Lucio-Gallego, et al.
Antioxidants (2023) Vol. 12, Iss. 1, pp. 183-183
Open Access | Times Cited: 10
Ferroptosis: mechanism, immunotherapy and role in ovarian cancer
Ke Guo, Miao Lu, Jianlei Bi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Recent Advances in Nanomaterial‐Mediated Cell Death for Cancer Therapy
Min Luo, Yuanmin Wang, Fukun Zhao, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 3
Self-amplification of oxidative stress with tumour microenvironment-activatable iron-doped nanoplatform for targeting hepatocellular carcinoma synergistic cascade therapy and diagnosis
Qiao-Mei Zhou, Yuan‐Fei Lu, Jia-Ping Zhou, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 21
The Role of Iron and Cobalt in Gynecological Diseases
Adrianna Ćwiertnia, Mateusz Kozłowski, Aneta Cymbaluk‐Płoska
Cells (2022) Vol. 12, Iss. 1, pp. 117-117
Open Access | Times Cited: 15
Depletion of PSMD14 suppresses bladder cancer proliferation by regulating GPX4
Changxin Jia, Xin Zhang, Tingting Qu, et al.
PeerJ (2023) Vol. 11, pp. e14654-e14654
Open Access | Times Cited: 8
The role and impact of alternative polyadenylation and miRNA regulation on the expression of the multidrug resistance-associated protein 1 (MRP-1/ABCC1) in epithelial ovarian cancer
Audrey Marjamaa, Bettine E. Gibbs, Chloe Kotrba, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Potential prognostic value of a eight ferroptosis-related lncRNAs model and the correlative immune activity in oral squamous cell carcinoma
Lin Qiu, Anqi Tao, Fei Liu, et al.
BMC Genomic Data (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 13
The mechanisms crosstalk and therapeutic opportunities between ferroptosis and ovary diseases
Ying Yao, Bin Wang, Yanbiao Jiang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 7
Long non‐coding RNA TPT1‐AS1 inhibits ferroptosis in ovarian cancer by regulating GPX4 via CREB1 regulation
Lei Cao, Yan Wang, Juanni Liu, et al.
American Journal of Reproductive Immunology (2024) Vol. 92, Iss. 2
Closed Access | Times Cited: 2
LC-MS untargeted metabolomics reveals metabolic disturbance and ferroptosis in MWCNTs-induced hepatotoxicity of Cyprinus carpio
Xiaochan Gao, Yimin Li, Jiaqi Shen, et al.
Aquatic Toxicology (2024) Vol. 275, pp. 107078-107078
Closed Access | Times Cited: 2
Inhibition of HOXC11 by artesunate induces ferroptosis and suppresses ovarian cancer progression through transcriptional regulation of the PROM2/PI3K/AKT pathway
Jun Li, Feng Lu, Yijun Yuan, et al.
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top